thromboxanes has been researched along with Coronary Artery Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bäck, M | 1 |
| Hohlfeld, T; Kelm, M; Polzin, A; Schrör, K; Zeus, T | 1 |
| Abrosimova, KA; Sokolov, EI; Zykova, AA | 1 |
| Kunsch, C; Malinin, A; Qiu, FH; Scott, R; Serebruany, V; Xu, XC | 1 |
| Daví, G; Grove, EL; Hedegaard, SS; Hvas, AM; Kristensen, SD; Refsgaard, J; Rocca, B | 1 |
| Grove, EL; Hedegaard, SS; Hvas, AM; Johnsen, HL; Kristensen, SD; Mortensen, J; Pedersen, SB | 1 |
| Fitzgerald, DJ; Maree, AO | 1 |
| Biczysko, W; Elikowski, W; Hanszke, E; Kruk-Zagajewska, A; Rzeźniczak, J; Zawilska, K | 1 |
| Badimon, L; Vilahur, G | 1 |
| Oian, P; Osterud, B | 1 |
| Hartig, F; Metz, J; Pill, J; Stegmeier, K | 1 |
| Billingham, ME; Fann, JI; Fong, LG; Miller, DC; Sarris, GE; Sokoloff, MH; Yun, KL | 1 |
| Maseri, A | 1 |
3 review(s) available for thromboxanes and Coronary Artery Disease
| Article | Year |
|---|---|
Aspirin and coronary artery disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Disease; Cyclooxygenase Inhibitors; Drug Resistance; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Models, Biological; Platelet Aggregation; Prostaglandins; Risk Factors; Thrombosis; Thromboxanes | 2004 |
Coronary atherothrombotic disease: progress in antiplatelet therapy.
Topics: Aspirin; Blood Platelets; Coronary Artery Disease; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Thromboxanes | 2008 |
Monocyte-platelet function and protection against cardiovascular disease.
Topics: Adult; Aged; Blood Platelets; Coronary Artery Disease; Coronary Disease; Coronary Thrombosis; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Monocytes; Thromboplastin; Thromboxanes; Tumor Necrosis Factor-alpha | 1996 |
1 trial(s) available for thromboxanes and Coronary Artery Disease
| Article | Year |
|---|---|
Selective thromboxane inhibition after vascular protectant AGI-1067: results of assessment of lipoprotein profiles (ALPS) biomarkers in vitro and in vivo substudy.
Topics: Adolescent; Adult; Aged; Biomarkers; Cells, Cultured; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Humans; Lipoproteins; Male; Middle Aged; Probucol; Risk Factors; Thromboxanes; Vascular Diseases; Young Adult | 2009 |
10 other study(ies) available for thromboxanes and Coronary Artery Disease
| Article | Year |
|---|---|
Leukotrienes and residual inflammatory risk in coronary artery disease.
Topics: Coronary Artery Disease; Humans; Leukotrienes; Myocardial Infarction; Thromboxanes | 2018 |
Dipyrone (metamizole) can nullify the antiplatelet effect of aspirin in patients with coronary artery disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Artery Disease; Dipyrone; Drug Interactions; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxanes | 2013 |
[Hormonal and Metabolic Differences in Patients With Coronary Artery Disease].
Topics: beta-Thromboglobulin; Coronary Artery Disease; Humans; Male; Myocardial Infarction; Norepinephrine; Thromboxanes | 2015 |
Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
Topics: Adult; Aged; Aspirin; Blood Platelets; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Patient Compliance; Platelet Aggregation; Platelet Aggregation Inhibitors; Tablets, Enteric-Coated; Thromboxanes; Time Factors | 2009 |
A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease.
Topics: Arachidonic Acid; Aspirin; Blood Platelets; Cells, Cultured; Collagen; Coronary Artery Disease; Cyclooxygenase 1; Drug Resistance; Enzyme Inhibitors; Epinephrine; Platelet Activation; Reproducibility of Results; Sensitivity and Specificity; Thromboxanes | 2010 |
Aspirin--first the good news...
Topics: Anticoagulants; Aspirin; Coronary Artery Disease; Humans; Thromboxanes | 2002 |
[Antiplatelet therapy can unmask an inherited bleeding disorder. Aspirin-like defect of platelets does not protect against atherosclerosis].
Topics: Aged; Aspirin; Blood Platelet Disorders; Coronary Artery Disease; Cyclooxygenase 1; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxanes | 2007 |
Effects of daltroban, a thromboxane (TX) A2 receptor antagonist, on lipid metabolism and atherosclerosis.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cells, Cultured; Cholesterol Esters; Coronary Artery Disease; Diet, Atherogenic; In Vitro Techniques; Lipid Metabolism; Male; Microsomes; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rabbits; Rats; Sterol O-Acyltransferase; Sulfonamides; Thromboxanes; Vasoconstrictor Agents | 1992 |
Dose response of fish oil versus safflower oil on graft arteriosclerosis in rabbit heterotopic cardiac allografts.
Topics: Animals; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Copper; Coronary Artery Disease; Cyclosporins; Fatty Acids; Fish Oils; Graft Rejection; Heart Transplantation; Oxidation-Reduction; Rabbits; Safflower Oil; Thromboxanes; Transplantation, Heterotopic; Transplantation, Homologous; Triglycerides | 1991 |
[Neurohumoral mechanisms in the physiopathology of coronary occlusion].
Topics: Coronary Artery Disease; Coronary Disease; Coronary Thrombosis; Coronary Vasospasm; Embolism; Epoprostenol; Humans; Neurotransmitter Agents; Plasminogen Activators; Platelet Aggregation; Thromboxanes; Vasoconstriction | 1985 |